ZKH Group posts top-line beat in Q4, shares edge higher

ZKH reported Q4 revenue of $365.68M vs $347.38M consensus, up 7.9% YoY, and returned to profitability with GAAP net profit of RMB4.8M (vs a RMB29.1M loss a year ago) and adjusted EPS of $0.01. GMV rose 8.5% YoY to RMB2,918.3M and customers increased 59.8% to 73,803, while gross margin slipped to 15.5% from 17.1% and operating expenses fell 3.0% YoY to RMB424.6M; non‑GAAP EBITDA was RMB19.7M vs -RMB13.3M. For full fiscal 2025, revenue was RMB8,987.7M (+2.6%) and the annual net loss narrowed to RMB139.7M from RMB268.0M.

Analysis

ZKH’s recent trajectory looks like a classic growth-at-the-margin story: customer acquisition is accelerating but unit economics are proving lumpy as the business scales inventory, private-label sourcing and fulfillment. That combination produces asymmetric outcomes — if supplier concentration and inventory turns improve, EBITDA can inflect materially; conversely, small slips in turnover or pricing power magnify gross-margin volatility because SG&A is already being levered down.

Near-term price action will be driven by two measurable pieces: next-quarter unit economics (inventory turns, days payable/receivable trends) and retention of the newly acquired customer cohorts. Both are observable within one to two quarterly releases and will re-rate the multiple quickly. Macro and supply-side tail risks are state-level industrial demand, RMB moves that alter import costs, and any squeeze on working capital financing that can force inventory markdowns within 1–3 quarters.

The non-obvious second-order is vendor concentration risk from scaling private-label: faster growth there can compress working-cap requirements for suppliers and invite exclusivity demands or upfront financing needs from suppliers, which would shift risk onto ZKH or force margin concessions. For competitors, digitally native MRO platforms with deeper supplier financing (or captive working-cap models) can rapidly replicate customer wins but not the private-label assortment without upfront inventory investment, creating a 3–12 month window where ZKH can convert higher-margin SKUs into durable revenue if it manages cash efficiently.

Key Decisions for Investors

• Long ZKH equity (tactical): initiate a small position sized ~1–2% of fund NAV, horizon 6–12 months. Use a protective stop at ~18% downside and a profit target near +50–70% if sequential margin recovery and cohort retention are confirmed over two quarters. Rationale: asymmetric upside if unit economics re-rate; downside capped by low absolute valuation and ability to hedge.
• Options hedge + leveraged upside: buy a 3-month 25-delta put to insure the equity leg against an earnings disappointment, and concurrently buy a 9-month call spread (buy a ~30% OTM call, sell a ~70% OTM call) to express leveraged upside with defined cost. This combination limits drawdown while keeping a convex payoff to margin improvement.
• Event play (short-dated volatility): buy an earnings straddle sized <0.5% NAV into the next quarterly release to capture a binary move—sell into any >20% intraday pop post-release. Timeframe: days around earnings. Risk: rapid implied-vol collapse if move is muted.
• Portfolio rotation: trim non-core cyclical exposure (e.g., reduce SMCI position by 25% where execution and demand profiles are more binary) and redeploy into ZKH’s idiosyncratic recovery thesis. This shifts beta from hardware cyclical risk to a company-specific operational de-risking trade.